000 01515 a2200457 4500
005 20250518023820.0
264 0 _c20190827
008 201908s 0 0 eng d
022 _a1878-1705
024 7 _a10.1016/j.intimp.2019.02.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLu, Jingli
245 0 0 _aInterleukin-33 prevents the development of autoimmune diabetes in NOD mice.
_h[electronic resource]
260 _bInternational immunopharmacology
_cMay 2019
300 _a9-15 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aApoptosis
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aDiabetes Mellitus, Type 1
_ximmunology
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aForkhead Transcription Factors
_xmetabolism
650 0 4 _aGene Expression Regulation
650 0 4 _aHomeostasis
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
650 0 4 _aInterleukin-33
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Inbred NOD
650 0 4 _aSignal Transduction
650 0 4 _aT-Lymphocytes, Regulatory
_ximmunology
650 0 4 _ap38 Mitogen-Activated Protein Kinases
_xmetabolism
700 1 _aLiang, Yan
700 1 _aZhao, Junjie
700 1 _aMeng, Haiyang
700 1 _aZhang, Xiaojian
773 0 _tInternational immunopharmacology
_gvol. 70
_gp. 9-15
856 4 0 _uhttps://doi.org/10.1016/j.intimp.2019.02.018
_zAvailable from publisher's website
999 _c29388176
_d29388176